Anzac Animal Health’s Zycosan Receives the US FDA’s Approval as First Injectable
Shots:
- The US FDA has approved Zycosan (pentosan polysulfate sodium inj.) that can help control the clinical signs & improve equine QoL for osteoarthritis in horses. Zycosan is sponsored by Anzac Animal Health
- The sponsor of Zycosan conducted a field study on horses who had lameness in one leg and were found to have osteoarthritis in the lame leg. On Day 28, more horses in the Zycosan treated group had improved lameness grades over the control group and the study results indicated that treatment with Zycosan at the labeled dose benefited horses with single limb lameness due to osteoarthritis
- Zycosan can be administered at a dose of 3mg/kg (1.4mg/lb) via intramuscular inj., qw for 4wks. in horses & is not for human use. The product is supplied in a 7.5ml single-use vial
Ref: dvm360 | Image: Anzac Animal Healths
Related Report:- Top 20 Animal Health Companies Based on 2021 Revenue
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
